dr. louis weiner on the t-dm1 mechanism of action in her2-positive breast cancer
Published 11 years ago • 703 plays • Length 0:57Download video MP4
Download video MP3
Similar videos
-
1:21
dr. louis weiner discusses the t-dm1 emilia trial for her2-positive breast cancer
-
2:51
dr. louis m. weiner on immunoconjugates
-
9:38
role of t-dm1 in her2-positive metastatic breast cancer
-
4:33
upfront t-dm1 in her2-positive breast cancer
-
1:07
dr. tripathy discusses impact of t-dm1 in her2 breast cancer
-
1:14
dr. cheng on the role of t-dm1 in her2 breast cancer
-
3:58
frontline t-dm1 in her2-positive metastatic breast cancer
-
2:00
dr. esteva discusses t-dm1 in her2-positive breast cancer
-
0:56
dr. jhaveri discusses the utility of t-dm1 in the neoadjuvant setting
-
1:31
dr. gwin on the mechanism of action of 𝞪-tea in her2-positive metastatic breast cancer
-
4:04
neoadjuvant t-dm1 in her2 early breast cancer
-
1:09
dr. burris discusses promise of t-dm1 in her2 breast cancer
-
1:13
dr. hamilton on the efficacy of trastuzumab deruxtecan in her2-low breast cancer
-
5:15
case review: t-dm1 for residual her2 breast cancer
-
1:29
tuxedo-1: trastuzumab deruxtecan for the treatment of her2-positive breast cancer brain metastases
-
1:20
updated results of destiny-breast03: t-dxd vs t-dm1 in metastatic her2 breast cancer
-
1:38
dr. debu tripathy discusses the updated emilia trial results for t-dm1
-
4:54
adjuvant t-dm1 for stage i her2 breast cancer
-
2:03
dr. lori goldstein on neoadjuvant treatment for her2 breast cancer